lexariabioscience.com (LEXX) Amount of Cash per Share

Symbol and logo of brand Lexaria Bioscience Corp. (LEXX)

The change in cash per share demonstrates the liquidity of Lexaria Bioscience (LEXX), where the 1.72 mark characterizes this parameter. The dynamics of reserves are driven by the DehydraTECH licensing model, which ensures high margins with zero costs. Success depends on the integration of the technology into hypertension and diabetes medications. This strategy creates powerful operating leverage, converting royalties into net profit.

Lexaria (LEXX) Cash per Share: for the period 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for Lexaria Bioscience (LEXX)

- cash and cash flow data:
Summary company analysis:Lexaria Bioscience
Flagship merchandise of Lexaria

This metric is calculated as the ratio of total cash to the number of shares outstanding, measuring real liquidity per share. The metric's dynamics are sensitive to share issuances and operating expenses, reflecting the efficiency of capital management. By analyzing changes in cash per share, an investor assesses the issuer's financial cushion. For Lexaria Bioscience (LEXX), this is critical when scaling DehydraTECH technology. A sufficient reserve ensures the development of a product line for the treatment of diabetes and hypertension.

Analysis of competing companies

Cash on Hand per Share Haleon Corp HLN|Cash per Single Share KVUE (Kenvue Health)|Verona Pharma plc - Cash Funds per Single Share|Jyong Biotech - Cash per Single Share|LGND: Cash Funds per Single Share|AMRX: Cash per Single Share|Cash on Hand per Share Perrigo Company plc|ALVO: Cash per Share|Liquidia (LQDA) - Cash per Share|Cash Funds per Share Galapagos N.V.|Cash per Single Share ANI Pharmaceuticals, Inc. (ANIP)|Cash per Share MNKD|AMPH (Amphastar Corp) - Amount of Cash per Share|Cash Funds per Share pacira.com PCRX|SPRY - Cash per Single Share|Theravance Biopharma, Inc. - Cash per Share|Amount of Cash per Share AQST (Aquestive Therapeutics, Inc.)|SCPH: Cash per Share|Tectonic Therapeutic Inc. - Amount of Cash per Share|TNXP (Tonix Pharma) - Cash per Share|SXTC: Amount of Cash per Share|Cash per Share EPRX|BHST - Cash on Hand per Share|eXoZymes - Cash per Single Share|Cash per Share oramed.com ORMP|ENTX - Cash Funds per Share|Cash Funds Calculated per Share MindWalk Holdings HYFT|ABVC: Cash per Share|Cash per Single Share Cumberland Pharmaceuticals Inc.|Cash Funds per Share Quantum BioPharma Limited|FGEN: Amount of Cash per Share|Cash per Share TELO|Rani Therapeutics Holdings, Inc. - Cash Funds per Single Share|Cash Funds per Share Synergy CHC Corp. SNYR|Amount of Cash per Share RLYB|PULM - Cash Funds per Share|Amount of Cash per Share PTHL (Pheton Holdings)|Aptorum (APM) - Cash Funds per Share|LYRA (Lyra Therapeutics) - Cash Funds per Share|Cash Funds per Share Impact BioMedical Inc|TNF Pharmaceuticals - Cash Money per Share|Cash per Share YCBD|Cash per Share PainReform Ltd. (PRFX)|Cash Funds per Share Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Cash Money per Share|OptiNose - Cash per Share|Cash Money per Share PIRS|PROC: Cash per Share|Petros - Amount of Cash per Share|Cash per Single Share QLI|SLRN: Amount of Cash per Share|Cash per Single Share TFFP (TFF Pharmaceuticals, Inc.)